Tdspharm Co., Ltd. (KOSDAQ:464280)
South Korea · Delayed Price · Currency is KRW 5,590.00
-10.00 (-0.18%)
Oct 8, 2026, 3:30 PM KST
Tdspharm Market Cap
Tdspharm has a market cap or net worth of 30.91 billion as of October 8, 2026. It is the 36,078th most valuable company in the world and the 2,161st biggest in South Korea. Its market cap has decreased by 42.84% in one year.
Market Cap
30.91B
Enterprise Value
17.05B
Revenue
32.90B
Global Rank
Country Rank
#2,161 South Korea
PE Ratio
5.74
ChartMarket Cap Chart
Since August 21, 2024, Tdspharm's market cap has decreased from 287.56B to 30.91B, a decrease of -89.25%. That is a compound annual growth rate of -64.88%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 8, 2026 | 30.91B | -43.25% |
| Dec 30, 2025 | 54.47B | -25.60% |
| Dec 30, 2024 | 73.22B | -74.54% |
| Aug 21, 2024 | 287.56B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Samsung Biologics | 60.57T |
| Celltrion | 41.67T |
| ALTEOGEN | 18.00T |
| Samsung Epis Holdings | 9.20T |
| LabGenomics | 43.21B |
| IMB Dx | 42.26B |
| HASS Corp. | 39.31B |
| BCWORLD PHARM. | 31.22B |